Frequently Asked Questions

Semaglutide is a medication that belongs to a class of drugs called GLP-1 receptor agonists. It works by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels and appetite. By increasing feelings of fullness and reducing appetite, semaglutide can lead to weight loss.

Yes, tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by targeting multiple pathways involved in appetite regulation and glucose metabolism, leading to weight loss.

While both semaglutide and tirzepatide are GLP-1 receptor agonists and can promote weight loss, tirzepatide also targets the GIP pathway, potentially offering additional benefits in terms of weight management compared to semaglutide alone.

Semaglutide and tirzepatide can be effective complements to traditional weight loss methods like diet and exercise, especially for individuals who have difficulty achieving weight loss through lifestyle changes alone. These medications work by targeting appetite regulation and metabolism, which can enhance the effectiveness of diet and exercise efforts.

Common side effects of semaglutide and tirzepatide may include nausea, vomiting, diarrhea, and decreased appetite. These side effects are usually mild to moderate in severity and tend to improve over time as the body adjusts to the medication.

Weight loss results with semaglutide and tirzepatide can vary depending on individual factors such as starting weight, diet, exercise habits, and adherence to medication. However, many people may start to see significant weight loss within the first few months of treatment.

The use of semaglutide and tirzepatide in combination with other weight loss medications or supplements should be carefully supervised by a healthcare professional to minimize the risk of drug interactions and adverse effects. Combining these medications with other weight loss interventions may enhance their effectiveness for some individuals.